How Safe Are Reduced Doses per Fraction in Target Volumes of 2^nd to 4^th Order in the Simultaneous Integrated Boost Irradiation Technique in Head and Neck Carcinoma Patients?

A. Buchali^1*, C. Schroeder^1,2, C. Boerrnert¹, I. Maekelburg¹, W. Huhnt¹, A. Franzen³

¹Department of Radiooncology, Ruppiner Kliniken GmbH, Neuruppin, Germany.
²Justus Liebig University, Giessen, Germany.
³Department of Otolaryngology, Ruppiner Kliniken GmbH, Neuruppin, Germany.

DOI: 10.4236/jct.2015.62023                

Abstract

Aim: The simultaneous irradiation of target volumes of different total dose levels using intensity modulated radiotherapy leads to reduced doses per fraction and longer treatment times in target volumes of 2^nd to 4^th order. Does the thereby caused reduced biological effectiveness induce an increased recurrence risk? The current work deals with the problem of recurrences of patients with head and neck carcinomas treated either with an intensitiy (IMRT) or with a volumetric modulated (VMAT) irradiation technique. Methods: From October 2002 to September 2014, 699 patients with carcinomas of the head and neck were irradiated using IMRT or VMAT. The median follow up of the patients was 21.9 months (2 to 145 months). Primary tumor regions (1^st order target volume) of 565 patients were treated with doses per fraction of 2 Gy. Accordingly, further 133 target volumes of the primary tumor received reduced doses per fraction. In 1 patient, the lymphatic drainage was treated solely without irradiation of the primary region. For the lympatic drainage, 854 1^st order target volumes were treated with a dose per fraction of 2 Gy. Reduced doses per fraction were applied to further 1780 target volumes. Results: 54 of 699 patients developed a recurrence in the primary tumor region after radio-(chemo) therapy, 4 patients developed a recurrence of the primary tumor and a unilateral recurrence of the lymphatic drainage, 2 patients a recurrence of the primary tumor and a bilateral lymph node recurrence. 18 patients showed an isolated unilateral recurrence and additionally 2 patients a bilateral recurrence of the lymphatic drainage. 619 patients stayed recurrence free. In primary tumor regions, receiving a dose per fraction of 2 Gy 55 patients (9.7%) developed a recurrence, whereas in target volumes receiving a reduced dose per fraction 5 patients (3.8%) developed a recurrence (p < 0.001). In lympatic drainage target volumes receiving a dose per fraction of 2 Gy, 25 target volumes (2.9%) developed a recurrence, whereas in target volumes receiving a reduced dose per fraction, 5 patients (0.3%) developed a recurrence (p = 0.001). Conclusion: The recurrence risk in target volumes of 2^nd to 4^th order was not increased due to reduced doses per fraction deposited by means of a simultaneous integrated boost technique. Therefore, the simultaneous irradiation of target volumes with different dose levels is safely applicable within one treatment plan.

Keywords

Head and Neck Carcinoma, Simultaneous Integrated Boost Technique, Dose Painting, Dose per Fraction, Recurrence Risk

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Collan, J., Kapanen, M., Makitie, A., et al. (2012) Submandibular Gland-Sparing Intensity Modulated Radiotherapy in the Treatment of Head and Neck Cancer: Sites of Locoregional Relapse and Survival. Acta Oncologica, 51, 735-742. http://dx.doi.org/10.3109/0284186X.2011.640348
[2]	Garden, A.S., Dong, L., Morrison, W.H., et al. (2013) Patterns of Disease Recurrence Following Treatment of Oropharyngeal Cancer with Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology, 85, 941-947. http://dx.doi.org/10.1016/j.ijrobp.2012.08.004
[3]	Van Gestel, D., Van Den Weyngaert, D., Schrijvers, D., et al. (2011) Intensity-Modulated Radiotherapy in Patients with Head and Neck Cancer: A European Single-Centre Experience. British Journal of Radiology, 84, 367-374. http://dx.doi.org/10.1259/bjr/67058055
[4]	Hoebers, F., Rios, E., Troost, E., et al. (2013) Definitive Radiation Therapy for Treatment of Laryngeal Carcinoma. Impact of Local Relapse on Outcome and Implicaions for Treatment Strategies. Strahlentherapie und Onkologie, 189, 834-841. http://dx.doi.org/10.1007/s00066-013-0414-2
[5]	Liauw, S.L., Amdur, R.J., Morris, C.G., et al. (2007) Isolated Neck Recurrence after Definitive Radiotherapy for Node-Positive Head and Neck Cancer: Salvage in the Dissected or Undissected Neck. Head Neck, 29, 715-719. http://dx.doi.org/10.1002/hed.20580
[6]	Ng, W.T., Lee, M.C.H., Hung, W.M., et al. (2011) Clinical Outcomes and Patterns of Failure after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 79, 420-428. http://dx.doi.org/10.1016/j.ijrobp.2009.11.024
[7]	Oksuz, D.C., Prestwich, R.J., Carey, B., et al. (2011) Recurrence Patterns of Locally Advanced Head and Neck Squamous Cell Carcinoma after 3D Conformal (Chemo)-Radiotherapy. Radiation Oncology, 24, 54. http://dx.doi.org/10.1186/1748-717X-6-54
[8]	Buchali, A., Schroder, C., Sidow, D., et al. (2013) Influence of the Radiation Dose to Slaivary Glands on Xerostomia in Patients with Head and Neck Carcinomas. JCT, 4, 188-194. http://dx.doi.org/10.4236/jct.2013.41028
[9]	Budach, V., Stuschke, M., Budach, W., et al. (2005) Hyperfractionated Accelerated Chemoradiation with Concurrent Fluorouracil-Mitomycin Is More Effective than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial. Journal of Clinical Oncology, 23, 1125-1135. http://dx.doi.org/10.1200/JCO.2005.07.010
[10]	Chen, J.L.Y., Huang, Y.S., Kuo, S.H., et al. (2013) Intensitiy Modulated Radiation Therapy for T4 Nasopharyngeal Carcinoma. Treatment Results and Locoregional Recurrence. Strahlentherapie und Onkologie, 189, 1001-1008. http://dx.doi.org/10.1007/s00066-013-0429-8
[11]	Kuhnt, T., Mueller, A.C., Pelz, T., Haensgen, G., Bloching, M., Koesling, S., et al. (2005) Impact of Tumor Control and Presence of Visible Necrosis in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy. Journal of Cancer Research and Clinical Oncology, 131, 758-764. http://dx.doi.org/10.1007/s00432-005-0018-z
[12]	Lambrecht, M., Dirix, P., Van den Bogaert, W. and Nuyts, S. (2009) Incidence of Isolated Regional Recurrence after Definitive (Chemo-) Radiotherapy for Head and Neck Squamous Cell Carcinoma. Radiotherapy and Oncology, 93, 498-502. http://dx.doi.org/10.1016/j.radonc.2009.08.038
[13]	Lambrecht, M., Nevens, D. and Nuyts, S. (2013) Intensity-Modulated Radiotherapy vs. Parotid-Sparing 3D Conformal Radiotherapy. Effect on Outcome and Toxicity in Locally Advanced Head and Neck Cancer. Strahlentherapie und Onkologie, 189, 223-229. http://dx.doi.org/10.1007/s00066-012-0289-7
[14]	Lau, H., Brar, S., Hao, D., MacKinnon, J., Yee, D. and Gluck, S. (2006) Concomitant Low-Dose Cisplatin and Three-Dimensional Conformal Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Analysis of Survival and Toxicity. Head and Neck, 28, 189-196. http://dx.doi.org/10.1002/hed.20324
[15]	Schoenfeld, G.O., Amdur, R.J., Morris, C.G., Li, J.G., Hinerman, R.W. and Mendenhall, W.M. (2008) Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physic, 71, 377-385. http://dx.doi.org/10.1016/j.ijrobp.2007.10.010
[16]	Moon, S.H., Jung, Y.S., Ryu, J.S., Choi, S.W., Park, J.Y., Yun, T., et al. (2011) Outcomes of Postoperative Simultaneous Modulated Accelerated Radiotherapy for Head-and-Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physic, 81, 140-149. http://dx.doi.org/10.1016/j.ijrobp.2010.04.068
[17]	Bockel, L.W., Monninkhof, E.M., Pameijer, F.A. and Terhaard, C.H.J. (2013) Importance of Tumor Volume in Supraglottic, and Glottic Laryngeal Carcinoma. Strahlentherapie und Onkologie, 189, 1011-1014.
[18]	Feng, M., Jabbari, S., Lin, A., Bradford, C.R., Chepeha, D.B., Teknos, T.N., et al. (2005) Predictive Factors of Local-Regional Recurrences Following Parotid Sparing Intensity Modulated or 3D Conformal Radiotherapy for Head and Neck Cancer. Radiotherapy & Oncology, 77, 32-38. http://dx.doi.org/10.1016/j.radonc.2005.07.008
[19]	Langendijk, J.A., Slotman, B.J., van der Waal, I., Doornaert, P., Berkof, J. and Leemans, C.R. (2005) Risk-Group Definition by Recursive Partitioning Analysis of Patients with Squamous Cell Head and Neck Carcinoma Treated with Surgery and Postoperative Radiotherapy. Cancer, 104, 1408-1417. http://dx.doi.org/10.1002/cncr.21340
[20]	Chen, J.Z., Le, Q.T., Han, F., Lu, L.Y., Huang, S.M., Lin, C.G., et al. (2013) Results of a Phase 2 Study Examining the Effects of Omitting Elective Neck Irradiation to Nodal Levels IV and Vb in Patients with N0-1 Nasopharyngeal Carcinoma. International Journal of Radiation Oncology, Biology, Physic, 85, 929-934. http://dx.doi.org/10.1016/j.ijrobp.2012.07.2356
[21]	Gao, Y., Zhu, G., Lu, J., Ying, H., Kong, L., Wu, Y., et al. (2010) Is Elective Irradiation to the Lower Neck Necessary for No Nasopharyngeal Carcinoma? International Journal of Radiation Oncology, Biology, Physic, 77, 1397-1402. http://dx.doi.org/10.1016/j.ijrobp.2009.06.062
[22]	Ho, F.C., Tham, I.M., Earnest, A., Lee, K.M. and Lu, J.J. (2012) Patterns of Regional Lymph Node Metastasis of Nasopharyngeal Carcinoma: A Meta-Analysis of Clinical Evidence. BMC Cancer, 12, 98. http://dx.doi.org/10.1186/1471-2407-12-98
[23]	Ng, S.H., Chang, J.T., Chan, S.C., Ko, S-F., Wang, H.M., Liao, C.T., et al. (2004) Nodal Metastasis of Nasopharyngeal Carcinoma: Patterns of Disease on MRI and FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging, 31, 1073-1080. http://dx.doi.org/10.1007/s00259-004-1498-9
[24]	Tang, L., Mao, Y., Liu, L., Liang, S., Chen, Y., Sun, Y., et al. (2009) The Volume to Be Irradiated during Selective Neck Irradiation in Nasopharyngeal Carcinoma: Analysis of the Spread Patterns in Lymph Nodes by Magnetic Resonance Imaging. Cancer, 115, 680-688. http://dx.doi.org/10.1002/cncr.24049
[25]	Begg, A.C. (2012) Predicting Recurrence after Radiotherapy in Head and Neck Cancer. Seminars in Radiation Oncology, 22, 108-118. http://dx.doi.org/10.1016/j.semradonc.2011.12.002
[26]	Cannon, D.M. and Lee, N.Y. (2008) Recurrence in Region of Spared Parotid Gland after Definitive Intensity-Modulated Radiotherapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physic, 70, 660-665. http://dx.doi.org/10.1016/j.ijrobp.2007.09.018
[27]	Lee, A.W.M., Sze, H. and Tong Ng, W. (2013) Is Selective Neck Irradiation Safe for Node-Negative Nasopharyngeal Cancer. International Journal of Radiation Oncology, Biology, Physic, 85, 902-903. http://dx.doi.org/10.1016/j.ijrobp.2012.09.010
[28]	Mendenhall, W.M. and Mancuso, A.A. (2009) Radiotherapy for Head and Neck Cancer—Is the “Next Level” Down? International Journal of Radiation Oncology, Biology, Physic, 73, 645-646. http://dx.doi.org/10.1016/j.ijrobp.2008.08.061
[29]	Peters, L.J., O’Sullivan, B., Giralt, J., Fitzgerald, T.J., Trotti, A., Bernier, J., et al. (2010) Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results from TROG 02.02. Journal of Clinical Oncology, 28, 2996-3001. http://dx.doi.org/10.1200/JCO.2009.27.4498
[30]	Buchali, A., Schroeder, C., Sidow, D. and Blank, E. (2013) Influence of the Radiation Dose to Salivary Glands on Xerostomia in Patients with Head and Neck Carcinomas. Journal of Cancer Therapy, 4, 188-194. http://dx.doi.org/10.4236/jct.2013.41028
[31]	Bourhis, J., Overgaard, J., Audry, H., Ang, K.K., Saunders, M., Bernier, J., et al. (2006) Hyperfractionated or Accelerated Radiotherapy in Head and Neck Cancer: A Meta-Analysis. Lancet, 368, 843-854. http://dx.doi.org/10.1016/S0140-6736(06)69121-6